• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数据拯救生命:优化常规临床数据以用于罕见病研究。

Data saves lives: optimising routinely collected clinical data for rare disease research.

机构信息

Population, Policy and Practice Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK.

Ulverscroft Vision Research Group, Great Ormond Street Institute of Child Health, University College London, London, UK.

出版信息

Orphanet J Rare Dis. 2023 Sep 11;18(1):285. doi: 10.1186/s13023-023-02912-1.

DOI:10.1186/s13023-023-02912-1
PMID:37697298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10496203/
Abstract

Necessity driven organisational change in the post-pandemic landscape has seen health care providers adopting innovations to manage and process health data. These include the use of 'real-world' datasets of routinely collected clinical information, enabling data-driven delivery. Rare disease risks being 'left-behind' unless our clinical and research communities engage with the challenges and opportunities afforded by the burgeoning field of health data informatics. We address the challenges to the meaningful use and reuse of rare disease data, and, through a series of recommendations around workforce education, harmonisation of taxonomy, and ensuring an inclusive health data environment, we highlight the role that those who manage rare disease must play in addressing them.

摘要

在后疫情时代,为满足需求而进行的组织变革促使医疗保健提供者采用创新手段来管理和处理健康数据。其中包括使用常规收集的临床信息的“真实世界”数据集,从而实现数据驱动的服务提供。如果临床和研究界不参与蓬勃发展的健康数据信息学领域带来的挑战和机遇,那么罕见病很可能会被忽视。我们解决了罕见病数据的有效使用和再利用面临的挑战,并通过围绕劳动力教育、分类法协调以及确保包容的健康数据环境方面的一系列建议,强调了管理罕见病的人员必须在解决这些问题方面发挥的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/10496203/3e6882677921/13023_2023_2912_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/10496203/7d0f88e18ef2/13023_2023_2912_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/10496203/3e6882677921/13023_2023_2912_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/10496203/7d0f88e18ef2/13023_2023_2912_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/10496203/3e6882677921/13023_2023_2912_Fig2_HTML.jpg

相似文献

1
Data saves lives: optimising routinely collected clinical data for rare disease research.数据拯救生命:优化常规临床数据以用于罕见病研究。
Orphanet J Rare Dis. 2023 Sep 11;18(1):285. doi: 10.1186/s13023-023-02912-1.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Sharing real-world data for public benefit: a qualitative exploration of stakeholder views and perceptions.为公共利益共享真实世界数据:利益相关者观点和看法的定性探索。
BMC Public Health. 2023 Jan 19;23(1):133. doi: 10.1186/s12889-023-15035-w.
4
Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review.绘制欧洲罕见病数据库图谱所面临的挑战,从组织、FAIR 和法律原则方面来看,这些挑战与基于机器学习的筛查技术相关:范围综述。
Front Public Health. 2023 Sep 15;11:1214766. doi: 10.3389/fpubh.2023.1214766. eCollection 2023.
5
The use of routinely collected computer data for research in primary care: opportunities and challenges.利用常规收集的计算机数据进行初级保健研究:机遇与挑战。
Fam Pract. 2006 Apr;23(2):253-63. doi: 10.1093/fampra/cmi106. Epub 2005 Dec 20.
6
'Grey nomad' travellers' use of remote health services in Australia: a qualitative enquiry of hospital managers' perspectives.“灰领游牧民”旅行者在澳大利亚使用远程医疗服务:对医院管理者观点的定性研究。
BMC Health Serv Res. 2022 Feb 5;22(1):151. doi: 10.1186/s12913-022-07580-8.
7
[Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?].面对2019冠状病毒病(COVID-19)大流行的卫生专业人员:心理健康风险有哪些?
Encephale. 2020 Jun;46(3S):S73-S80. doi: 10.1016/j.encep.2020.04.008. Epub 2020 Apr 22.
8
RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic framework.RD-RAP:超越罕见病患者登记处,设计全面的数据和分析框架。
Orphanet J Rare Dis. 2019 Jul 12;14(1):176. doi: 10.1186/s13023-019-1139-9.
9
When past is not a prologue: Adapting informatics practice during a pandemic.当过去不是序幕:在大流行期间调整信息学实践。
J Am Med Inform Assoc. 2020 Jul 1;27(7):1142-1146. doi: 10.1093/jamia/ocaa073.
10
Training and cultivating the translational science workforce: Responses of Clinical and Translational Science Awards program hubs to the COVID-19 pandemic.培训和培养转化科学人才队伍:临床与转化科学奖计划中心对 COVID-19 大流行的反应。
Clin Transl Sci. 2023 Jan;16(1):43-49. doi: 10.1111/cts.13437. Epub 2022 Nov 29.

引用本文的文献

1
Hospital administrators as forgotten partners in rare disease care: a call to action by the international hospital federation's global rare pediatric disease network.医院管理人员作为罕见病护理中被遗忘的合作伙伴:国际医院联合会全球罕见儿科疾病网络的行动呼吁
Orphanet J Rare Dis. 2024 Dec 4;19(1):456. doi: 10.1186/s13023-024-03459-5.
2
The creation of an adaptable informed consent form for research purposes to overcome national and institutional bottlenecks in ethics review: experience from rare disease registries.创建一份适用于研究目的的知情同意书,以克服伦理审查中的国家和机构瓶颈:来自罕见病登记处的经验。
Front Med (Lausanne). 2024 Apr 17;11:1384026. doi: 10.3389/fmed.2024.1384026. eCollection 2024.

本文引用的文献

1
A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease.系统评价非癌症相关罕见病临床基因组和遗传服务获取的地理不平等性。
Eur J Hum Genet. 2022 Jun;30(6):645-652. doi: 10.1038/s41431-021-01022-5. Epub 2022 Jan 20.
2
Childhood rare diseases and the UN convention on the rights of the child.儿童罕见病与《联合国儿童权利公约》。
Orphanet J Rare Dis. 2021 Dec 24;16(1):523. doi: 10.1186/s13023-021-02153-0.
3
How to design a registry for undiagnosed patients in the framework of rare disease diagnosis: suggestions on software, data set and coding system.
如何在罕见病诊断框架下为未确诊患者设计登记系统:关于软件、数据集和编码系统的建议。
Orphanet J Rare Dis. 2021 May 1;16(1):198. doi: 10.1186/s13023-021-01831-3.
4
Toward a Medical "Ecology of Attention".迈向医学“注意力生态学”。
N Engl J Med. 2021 Jan 28;384(4):299-301. doi: 10.1056/NEJMp2027190. Epub 2021 Jan 23.
5
Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic.远程风湿病学克服资源有限环境下医疗保健的社会经济障碍:COVID-19 大流行的经验教训。
Rheumatology (Oxford). 2021 Jul 1;60(7):3369-3379. doi: 10.1093/rheumatology/keaa791.
6
COVID-19 Pandemic Health Disparities and Pediatric Health Care-The Promise of Telehealth.新冠疫情下的健康差异与儿童医疗保健——远程医疗的前景
JAMA Pediatr. 2021 Apr 1;175(4):345-346. doi: 10.1001/jamapediatrics.2020.5097.
7
When the EMR Stole My Pen.当电子病历抢走了我的笔。
N Engl J Med. 2020 Aug 20;383(8):708-709. doi: 10.1056/NEJMp2000272.
8
A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.罕见病治疗系统评价撰写指南,以生成符合 FAIR 原则的数据集合:构建 Treatabolome。
Orphanet J Rare Dis. 2020 Aug 12;15(1):206. doi: 10.1186/s13023-020-01493-7.
9
Bringing NHS data analysis into the 21st century.将国民医疗服务体系(NHS)数据分析带入21世纪。
J R Soc Med. 2020 Oct;113(10):383-388. doi: 10.1177/0141076820930666. Epub 2020 Jul 16.
10
Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.全球远程医疗在卫生系统中的实施和整合,以抗击 COVID-19 大流行:行动呼吁。
JMIR Public Health Surveill. 2020 Apr 2;6(2):e18810. doi: 10.2196/18810.